Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
Machine learning method allows to differentiate kidney masses in CT scans

A machine learning method with a convolutional neural network (CNN) could work for the evaluation of small solid kidney masses in computed tomography (CT).

The article published in the American Journal of Roentgenology showed progress on this new diagnostic method. Researchers at Okayama University in Japan studied 1807 imaging sets of 168 solid renal masses less than or equal to 4 cm, diagnosed with CT in 159 patients.

The masses were classified as malignant (136), and benign (32), on a 5-point scale. Takashi Tanaka, lead author of the research explained the classification system: " "four were used for augmentation and supervised training (48,832 images), and one was used for testing (281 images)."

The CNN Model did not find a significant size difference between benign and malignant masses, however, the AUC value of the spinal corticomedullary was found to be greater than that of other phases. In addition, 88% accuracy was obtained in the images of that phase.

The results showed that the corticomedullary phase was an important predictor for determining whether the mass was malignant or not, compared to variables using other models such as the patient's age or mass size.

Outstanding news

News by country

Share

Digital Health in the world

  • — Science Brief: Omicron (B.1.1.529) Variant/CDC updates
    See more
  • —Coronavirus resource center/Johns Hopkins
    See more
  • — Epidemiological tracing of COVID-19 contacts / Johns Hopkins Course
    See more
  • — SARS-CoV-2 infection behavior / FCS calculator
    See more
  • — Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic/ Article The Lancet
    See more
  • —Genomic Epidemiology Tracker/GISAID
    See more
  • — Mexican Genomic Surveillance Consortium
    See more
Secured By miniOrange